Certified

Each lecture is accredited with 2 CME points by the Medical Association (Landesärztekammer).

MS Specialist certification powered by KKNMS

22nd September 2026 - 5.15 PM

Prof. Burkhardt Becher, PhD (Zurich)

Integrative Single-Cell and Systems Medicine Approaches to Inflammatory and Malignant Disease

Tuesday, September 22, 2026
5:15 PM - 6:00 PM
Hybrid: Neurozentrum Seminar rooms 1+2 (HG) & Zoom
Hosts: Heinz Wiendl, Christian Keller & Rick Dersch

2 CME points

Program

2026		2027
November 3	Mikael Simons (Munich)	January 12	Francisco Quintana (Harvard)
November 17	Josep Dalmau (Barcelona)	February 2	Nils Erik Gilhus (Bergen)
December 1	Britta Engelhardt (Bern)	March 9	Roland Martin (Zurich)
December 15	Jonathan Kipnis (St. Louis)	April 27	Assunta Dal-Bianco (Vienna)
		June 01	Jacqueline Palace (Oxford)
		July 07	Florian Scherer (Freiburg)

Past events

2026

Alexander Flügel, Prof MD (Göttingen): The role of the lung in CNS autoimmunity

Alexandre Prat, Prof MD (Montreal): Translational Neuroimmunology and the Role of the Brain Endothelium in Neuroinflammation

Andreas Meisel, Prof MD (Berlin): Therapeutic Innovation in Myasthenia Gravis: Mechanistic Drivers and Future Trajectories

Christian Münz, Prof PhD (Zurich): How a human tumor virus might cause autoimmunity

Patrick Waters, Prof PhD (Oxford): Antibodies and Assays in Neurology

Sarah Mundt, MD (Zurich): Mapping and Targeting Phagocytes to Decode Their Roles in CNS Inflammation

Sini Laakso, MD (Helsinki): Translational Immunology in Myasthenia Gravis: Lessons from Fine Needle Aspirations of Lymph Nodes in Neuroimmunological Diseases

2025

Benjamin Segal, Prof MD (Columbus): Age-Associated Expansion of Natural IgM+ Fcrl5+ B1 Cell Clones: Drivers of Progressive MS and Targets for Therapy

Edoardo Galli, MD PhD (Basel): From High-Dimensional Space to Precision Medicine - mapping the Immune System in Multiple Sclerosis

Fabienne Brilot, Prof PhD (Sydney): MOGAD - the next Challenges

Falk Nimmerjahn, Prof PhD (Erlangen): Immunglobulin G as a Therapeutic for Autoimmunity – from cytotoxic Activity to Immunomodulation

Habib Ganjgahi, PhD (Oxford): Big data modelling on MS: probabilistic Machine Learning and generative AI approaches

Isaak Quast, PhD (Monash): Regulation of B cell Responses by Cytokines and Antibodies

Johanna Oechtering, MD (Basel): The Role of IgM and Complement in Multiple Sclerosis

Jon Laman, Prof MD (Groningen): CD40 Ligand Immunotherapy of MS from Animal Model to Phase 3 Trials

Kevin Rostásy, Prof MD (Datteln): MOGAD - Spectrum Disorder in Children

Manuel Comabella, MD PhD (Barcelona): Interaction between human cytomegalovirus and Epstein-Barr virus in multiple sclerosis

Viktoria Wagner, PhD (Stanford): MiRNAs as potential regulators of the aging phenotype and promising novel therapy targets for age-related diseases